Chemical-structure (Chemical Structure)
Topiramate
Product Images NDC 50090-3931
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 50090-3931). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1jpg (Figure 1)
This is a graph showing the cumulative rates for time to first seizure for two groups of people taking different doses of topiramate medication. The first group (N=234) took a daily dose of 50 mg and the second group (N=236) took a daily dose of 400 mg. The graph shows that the group taking the higher dose had a lower rate of seizures over time, with a significant difference in the rates between the two groups (p=0.0002). The x-axis shows time in days and the y-axis represents the cumulative rate of seizures.*
Figure-2 (Figure 2)
This is a not-available description. The text is not informative enough to generate a useful description.*
Label Image (Lbl500903931)
This appears to be a product label or packaging information for a medication called Topiramate. The product number is listed as 6137-0, and the medication comes in a 25g size with 60 tablets per container. This information may be helpful for identifying the medication and dosage for individuals who have been prescribed Topiramate.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
